COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

Publication: 2021- : Basel, Switzerland : MDPI
Original Publication: Toronto : Multimed, c1994-

COVID-19/*etiology ; Esophageal Neoplasms/*surgery ; Esophagectomy/*adverse effects ; Postoperative Complications/*virology; Adult ; Aged ; COVID-19/diagnostic imaging ; Esophageal Neoplasms/pathology ; Esophagogastric Junction/pathology ; Humans ; Male ; Postoperative Complications/diagnostic imaging

The coronavirus disease 2019 (COVID-19) pandemic has had a substantial impact on the provision of medical healthcare. Due to an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) transmission, elective surgical treatment has been suspended in many centers. The effects of COVID-19 in the early post-operative period after esophagectomy remains unknown. In this report, we present three cases of patients diagnosed with esophago-gastric junction cancer who were scheduled for elective esophagectomy with a curative intention during second wave of COVID-19 pandemic in a single high-volume tertiary center. Despite all available safety measures, one of the patients developed COVID-19 pneumonia on post-operative day two, leading to an impaired respiratory function and increased pleural fluid collection from the chest tube, resulting in a prolonged time of hospital stay. Finding a good balance between the COVID-19-related perioperative risks and consequences of delaying surgical treatment in patients diagnosed with esophago-gastric cancer is a challenge. In order to achieve the best possible outcome, care must be taken to ensure availability of necessary treatment options and to reduce the risk of SARS-Cov-2 transmission perioperatively.

J Natl Compr Canc Netw. 2020 Mar 20;:1-4. (PMID: 32197238)
Ann Surg. 2020 Jul;272(1):e27-e29. (PMID: 32221117)
Indian J Surg Oncol. 2013 Jun;4(2):105-11. (PMID: 24426709)
Lancet. 2020 Jul 4;396(10243):27-38. (PMID: 32479829)
Lancet Oncol. 2011 Jul;12(7):681-92. (PMID: 21684205)
Lancet Oncol. 2020 Mar;21(3):335-337. (PMID: 32066541)
J Thorac Cardiovasc Surg. 2021 Jan 30;:. (PMID: 33642100)
World J Surg. 2020 Jun;44(6):1695-1698. (PMID: 32246185)
Dis Esophagus. 2020 Sep 4;33(9):. (PMID: 32816020)
Ann Med Surg (Lond). 2020 Oct;58:14-19. (PMID: 32864124)
N Engl J Med. 2012 May 31;366(22):2074-84. (PMID: 22646630)
Ann Surg. 2004 Nov;240(5):791-800. (PMID: 15492560)
Ann Thorac Surg. 2004 Oct;78(4):1170-6; discussion 1170-6. (PMID: 15464465)
Ann Gastroenterol. 2020 Sep-Oct;33(5):453-458. (PMID: 32879590)
Lancet Oncol. 2020 Apr;21(4):e181. (PMID: 32142621)
J Clin Oncol. 2014 Aug 10;32(23):2416-22. (PMID: 24982463)
J Laparoendosc Adv Surg Tech A. 2019 Aug;29(8):989-994. (PMID: 31246532)
Sci Rep. 2019 Aug 14;9(1):11856. (PMID: 31413282)
Clinics (Sao Paulo). 2021 Feb 05;76:e2483. (PMID: 33567049)

Keywords: COVID-19; esophagectomy; gastro-esophageal junction cancer; pneumonia

Date Created: 20210403 Date Completed: 20210416 Latest Revision: 20210416

20221213

PMC8025810

10.3390/curroncol28020128

33801652